EXAPRIDE 250MCG INJECTION 1.2ML

EXAPRIDE 250MCG INJECTION 1.2ML belongs to the class of 'anti-diabetic medicines' primarily used to improve blood sugar control in adults with type 2 diabetes mellitus (non-insulin-dependent diabetes). It is used as an adjunct to diet. Diabetes mellitus is a metabolic disease that causes high blood sugar levels. It occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant to breaking down the glucose to produce energy (insulin resistance) or when the pancreas (an organ behind the stomach) produces little or no insulin at all.

EXAPRIDE 250MCG INJECTION 1.2ML contains Exenatide that belongs to the class of 'incretin mimetics'. Exenatide works by increasing insulin release from the pancreas during high blood sugar levels (after meals) and decreasing the amount of sugar the liver makes. 

Your doctor will decide the dose and duration based on your medical condition. Some common side effects of EXAPRIDE 250MCG INJECTION 1.2ML include nausea, vomiting, diarrhoea, dizziness, nervousness/feeling jittery, upset stomach, constipation, and injection site reactions like pain/swelling/itching. These side effects are not familiar to everyone and vary individually. If you notice any side effects that are not manageable, please consult your doctor. 

Before starting EXAPRIDE 250MCG INJECTION 1.2ML, let your doctor know if you have a history of heart, kidney or liver diseases. Do not take or stop this medicine if the doctor did not advise you. It is advised to limit your alcohol intake while using EXAPRIDE 250MCG INJECTION 1.2ML to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting EXAPRIDE 250MCG INJECTION 1.2ML. EXAPRIDE 250MCG INJECTION 1.2ML may cause hypoglycaemia (low blood sugar levels) and dizziness affecting your driving ability; hence drive or operate machinery only when you feel better. EXAPRIDE 250MCG INJECTION 1.2ML is not recommended for children and adolescents under 18 years of age.

EXAPRIDE 250MCG INJECTION 1.2ML contains 'Exenatide' and is used to treat type 2 diabetes mellitus. It is an incretin mimetic that mimics the action of a natural hormone called Incretin (metabolic hormone, which stimulates a decrease in blood glucose levels). It works by increasing insulin release from the pancreas during high blood sugar levels (after meals) and decreases the amount of sugar the liver makes. EXAPRIDE 250MCG INJECTION 1.2ML is used as an adjunct to diet and exercise to improve glycemic control.

• Nausea
• Vomiting
• Diarrhoea
• Dizziness
• Nervousness/feeling jittery
• Upset stomach
• Constipation
• Injection site reactions like pain/swelling/itching

Brief your medical history to the doctor if you have any heart, kidney or liver diseases, pancreatitis (inflammation of the pancreas), gall stones, gastroparesis (delayed gastric emptying), hypoglycaemia (low blood sugar levels), low platelet levels, or type 1 diabetes before starting EXAPRIDE 250MCG INJECTION 1.2ML. Do not share an injection pen, cartridge, or syringe with another person, even if the needle is changed. It is advised to limit your alcohol intake while using EXAPRIDE 250MCG INJECTION 1.2ML to avoid low blood sugar levels further. Pregnant and breastfeeding women should consult their doctor before starting this medication. EXAPRIDE 250MCG INJECTION 1.2ML may make you feel dizzy, hence drive and operate machinery only when you feel better. EXAPRIDE 250MCG INJECTION 1.2ML is not recommended for children and adolescents under 18 years of age.

Drug-Drug Interaction: EXAPRIDE 250MCG INJECTION 1.2ML may interact with blood thinners (warfarin), high blood pressure medicines (propranolol, metoprolol), glaucoma eye drops (timolol), water pills, cholesterol-lowering drugs (lovastatin), and pain medicines. If you take antibiotics or birth control pills, maintain a gap of at least an hour before using EXAPRIDE 250MCG INJECTION 1.2ML.

Drug-Food Interaction: Limit alcohol intake since it affects blood sugar levels. Avoid fatty foods and include healthy carbohydrates in your diet.

Drug-Disease Interaction: Tell your doctor before using EXAPRIDE 250MCG INJECTION 1.2ML if you have a medical history of allergic reactions to medicines, heart, kidney or liver diseases, low platelet levels, pancreatitis, gastroparesis, gall bladder disease, or hypoglycaemia. EXAPRIDE 250MCG INJECTION 1.2ML is contraindicated in patients with multiple endocrine neoplasia type 2, diabetic ketoacidosis (diabetes complication where the body produces excess blood acids (ketones)), and personal or family history of thyroid cancer.

• WARFARIN
• PROPRANOLOL
• METOPROLOL
• TIMOLOL
• LOVASTATIN

• Maintain a fibre-rich diet and include healthy carbohydrates from fruits, vegetables and whole grains to maintain blood glucose levels.
• Eat at regular intervals.
• Monitor your weight and exercise regularly to keep your heart healthy.
• Your doctor also guides you on noticing and managing the early symptoms of high/low blood sugar levels.
• Gastrointestinal side effects can be managed with simple modifications in your lifestyle. These include cutting down on sugars and fatty foods and avoiding carbonated drinks and foods that cause gas.

• It is advised to monitor your blood sugar levels regularly.
• EXAPRIDE 250MCG INJECTION 1.2ML is not indicated for patients with type 1 diabetes or diabetic ketoacidosis. 
• Exenatide is not recommended if you have a personal/family history of a certain type of cancer (medullary thyroid carcinoma) or a certain inherited disease (multiple endocrine neoplasia syndrome type 2 or MEN 2).

Diabetes mellitus, or adult-onset diabetes, is a metabolic disease that causes high blood sugar levels. It is type 2 diabetes and occurs when the insulin (a hormone produced by the beta cells of the pancreas) is resistant in breaking the glucose to produce energy (insulin resistance), or the pancreas (an organ behind the stomach) produces little or no insulin at all. This disease mostly occurs in people above 40 years but can also occur in childhood based on the risk factors. The treatment includes oral glucose-lowering medicines and insulin shots.